Authors:
Bocchino, M
Ledru, E
Debord, T
Gougeon, ML
Citation: M. Bocchino et al., Increased priming for interleukin-12 and tumour necrosis factor alpha in CD64 monocytes in HIV infection: modulation by cytokines and therapy, AIDS, 15(10), 2001, pp. 1213-1223
Authors:
Hance, P
Fabre, R
Rapp, C
Debord, T
Tram, C
Citation: P. Hance et al., A case of Francisella tularensis suppurative lymphadenitis in the Nantes area, and the efficacy of fluoroquinoles, MED MAL INF, 30(1), 2000, pp. 57-58
Authors:
Molina, JM
Cheuc, G
Ferchal, F
Journot, V
Pellegrin, I
Sombardier, MN
Rancinan, C
Cotte, L
Madelaine, I
Debord, T
Decazes, JM
Citation: Jm. Molina et al., Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients, ANTIVIR TH, 4, 1999, pp. 71-74
Authors:
Molina, JM
Chene, G
Ferchal, F
Journot, V
Pellegrin, I
Sombardier, MN
Rancinan, C
Cotte, L
Madelaine, I
Debord, T
Decazes, JM
Citation: Jm. Molina et al., The ALBI trial: A randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus, J INFEC DIS, 180(2), 1999, pp. 351-358
Authors:
Boullier, S
Poquet, Y
Debord, T
Fournie, JJ
Gougeon, ML
Citation: S. Boullier et al., Regulation by cytokines (IL-12, IL-15, IL-4 and IL-10) of the V gamma 9V delta 2 T cell response to mycobacterial phosphoantigens in responder and anergic HIV-infected persons, EUR J IMMUN, 29(1), 1999, pp. 90-99